HCM
BHC icon

Hoplite Capital Management’s Bausch Health BHC Stock Holding History

Hoplite Capital Management’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-586,716
Closed -$105M – 29
2015
Q3 		$105M Sell
586,716
-287,573
-33% -$67.1M 3.96% 12
2015
Q2 		$194M Sell
874,289
-88,432
-9% -$19.6M 5.2% 4
2015
Q1 		$191M Sell
962,721
-410,708
-30% -$72.9M 5.9% 3
2014
Q4 		$197M Hold
1,373,429
– – 5.44% 3
2014
Q3 		$180M Sell
1,373,429
-77,026
-5% -$9.18M 4.6% 2
2014
Q2 		$183M Buy
1,450,455
+577,856
+66% +$73.7M 4.71% 5
2014
Q1 		$115M Sell
872,599
-516,354
-37% -$70.6M 3.17% 15
2013
Q4 		$163M Buy
1,388,953
+250,733
+22% +$27.5M 4.59% 4
2013
Q3 		$119M Hold
1,138,220
– – 4.22% 9
2013
Q2 		$98M Buy
+1,138,220
New +$89.7M 3.42% 10

Other funds holding BHC

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Hoplite Capital Management's BHC Position: Q4 2015 in Review

Hoplite Capital Management sold out of Bausch Health (BHC) in Q4 2015, closing a stake of 586,716 shares — an estimated $105M sold.

Hoplite Capital Management first reported a position in BHC in Q2 2013 and held it in 10 quarters. The position peaked at $197M in Q4 2014. 451 funds tracked by Wall St. Rank hold BHC as of Q4 2015.

  • Hoplite Capital Management reported no remaining Bausch Health position as of Q4 2015 after selling out during the quarter.
  • Hoplite Capital Management sold 586,716 Bausch Health shares in Q4 2015, an estimated $105M.
  • Hoplite Capital Management first reported a position in Bausch Health in Q2 2013 and held it in 10 quarters.
  • Hoplite Capital Management's Bausch Health position peaked at $197M in Q4 2014.
  • 451 funds tracked by Wall St. Rank held Bausch Health as of Q4 2015.

Based on Hoplite Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.